Long-term skin allograft survival after short-term cyclosporin treatment in a patient with massive burns.
In a child with extensive burns, cyclosporin was given to extend the survival of cadaveric skin allografts obtained from numerous unmatched donors. No evidence of graft rejection was seen, either during treatment or in the 2 years after cyclosporin was withdrawn.